NGH.H — Nexia Health Technologies Income Statement
0.000.00%
TechnologyMicro Cap
Annual income statement for Nexia Health Technologies, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
R2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | — | — | 0.479 | 1.5 | 1.45 |
Operating Profit | 0 | 0 | -0.479 | -1.5 | -1.45 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.97 | -0.81 | -0.453 | -1.28 | -1.45 |
Net Income After Taxes | -0.97 | -0.81 | -0.453 | -1.28 | -1.45 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.75 | -0.923 | 1.03 | -1.28 | -1.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -3.75 | -0.923 | 1.03 | -1.28 | -1.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.01 | -0.009 | -0.005 | -0.013 | -0.015 |
Dividends per Share |